scispace - formally typeset
I

Iris E. C. Sommer

Researcher at University Medical Center Groningen

Publications -  454
Citations -  20580

Iris E. C. Sommer is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Schizophrenia & Medicine. The author has an hindex of 68, co-authored 394 publications receiving 16545 citations. Previous affiliations of Iris E. C. Sommer include University of Toronto & University of Michigan.

Papers
More filters
Journal ArticleDOI

The clinical course of schizophrenia in women and men-a nation-wide cohort study.

TL;DR: The results suggest a diagnostic delay for women with schizophrenia, which might be shortened by screening women aged 20–65 participating in affective disorder programs, and clinicians should take care not to undertreatWomen with schizophrenia.
Journal ArticleDOI

Aberrations in the arcuate fasciculus are associated with auditory verbal hallucinations in psychotic and in non-psychotic individuals

TL;DR: As increased MTR in the arcuate fasciculus was present in both hallucinating groups, a specific association with AVH seems plausible, and a general decrease in fractional anisotropy for almost all bundles was observed in the patient group, but not in the non‐psychotic individuals withAVH.
Journal ArticleDOI

A novel concurrent TMS-fMRI method to reveal propagation patterns of prefrontal magnetic brain stimulation.

TL;DR: The propagation of TMS‐induced activity from the DLPFC to sgACC may be an accurate biomarker for rTMS efficacy and further research is required to determine whether this method can contribute to the selection of patients with treatment resistant MDD who will respond to rT MS treatment.
Journal ArticleDOI

Congenital supratentorial arachnoidal and giant cysts in children: a clinical study with arguments for a conservative approach

TL;DR: In this article, the authors report on 19 children with arachnoidal cysts of varying location and size, and the mean follow-up time is 6 years and the evolution of presenting symptoms, the developmental course, the occurrence of complications, the surgical intervention performed and its outcome are described.
Journal ArticleDOI

Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.

TL;DR: Estrogens and SERMs could be effective augmentation strategies in the treatment of women with schizophrenia, although potential side effects, partially associated with longer duration use, should be taken into account.